Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials.
Ducrocq, Gregory; Steg, Philippe Gabriel; Van't Hof, Arnoud; Zeymer, Uwe; Mehran, Roxana; Hamm, Christian W; Bernstein, Debra; Prats, Jayne; Deliargyris, Efthymios N; Stone, Gregg W.
Eur Heart J Acute Cardiovasc Care
; 6(7): 659-665, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27287251
Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
Antithrombotic treatment during coronary angioplasty after failed thrombolysis: strategies and prognostic implications. Results of the RESPIRE registry.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS-AMI trials.
Low-dose antithrombotic treatment in coronary thrombosis of Kawasaki disease.
Intracoronary thrombolytic therapy: a treatment option for failed mechanical thrombectomy.
Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants.
Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective.